Passed by the Senate April 19, 2005 YEAS 45   BRAD OWEN ________________________________________ President of the Senate Passed by the House April 6, 2005 YEAS 94   FRANK CHOPP ________________________________________ Speaker of the House of Representatives | I, Thomas Hoemann, Secretary of the Senate of the State of Washington, do hereby certify that the attached is SUBSTITUTE SENATE BILL 5841 as passed by the Senate and the House of Representatives on the dates hereon set forth. THOMAS HOEMANN ________________________________________ Secretary | |
Approved May 13, 2005. CHRISTINE GREGOIRE ________________________________________ Governor of the State of Washington | May 13, 2005 - 3:32 p.m. Secretary of State State of Washington |
State of Washington | 59th Legislature | 2005 Regular Session |
READ FIRST TIME 03/02/05.
AN ACT Relating to the prevention, diagnosis, and treatment of asthma; amending RCW 41.05.013; adding a new section to chapter 28A.210 RCW; adding a new section to chapter 43.70 RCW; and creating a new section.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 The legislature finds that:
(1) Asthma is a dangerous disease that is growing in prevalence in
Washington state. An estimated five hundred thousand residents of the
state suffer from asthma. Since 1995, asthma has claimed more than
five hundred lives, caused more than twenty-five thousand
hospitalizations with costs of more than one hundred twelve million
dollars, and resulted in seven million five hundred thousand missed
school days. School nurses have identified over four thousand children
with life-threatening asthma in the state's schools.
(2) While asthma is found among all populations, its prevalence
disproportionately affects low-income and minority populations.
Untreated asthma affects worker productivity and results in unnecessary
absences from work. In many cases, asthma triggers present in
substandard housing and poorly ventilated workplaces contribute
directly to asthma.
(3) Although research continues into the causes and cures for
asthma, national consensus has been reached on treatment guidelines.
People with asthma who are being treated in accordance with these
guidelines are far more likely to control the disease than those who
are not being treated and therefore are less likely to experience
debilitating or life-threatening asthma episodes, less likely to be
hospitalized, and less likely to need to curtail normal school or work
activities. With treatment, most people with asthma are able to live
normal, active lives.
(4) Up to one-third of the people with asthma have not had their
disease diagnosed. Among those with diagnosed asthma, thirty to fifty
percent are not receiving medicines that are needed to control the
disease, and approximately eighty percent of diagnosed asthmatics are
not getting yearly spirometry measurements that are a key element in
monitoring the disease.
NEW SECTION. Sec. 2 A new section is added to chapter 28A.210
RCW to read as follows:
(1) The superintendent of public instruction and the secretary of
the department of health shall develop a uniform policy for all school
districts providing for the in-service training for school staff on
symptoms, treatment, and monitoring of students with asthma and on the
additional observations that may be needed in different situations that
may arise during the school day and during school-sponsored events.
The policy shall include the standards and skills that must be in place
for in-service training of school staff.
(2) All school districts shall adopt policies regarding asthma
rescue procedures for each school within the district.
(3) All school districts must require that each public elementary
school and secondary school grant to any student in the school
authorization for the self-administration of medication to treat that
student's asthma or anaphylaxis, if:
(a) A health care practitioner prescribed the medication for use by
the student during school hours and instructed the student in the
correct and responsible use of the medication;
(b) The student has demonstrated to the health care practitioner,
or the practitioner's designee, and a professional registered nurse at
the school, the skill level necessary to use the medication and any
device that is necessary to administer the medication as prescribed;
(c) The health care practitioner formulates a written treatment
plan for managing asthma or anaphylaxis episodes of the student and for
medication use by the student during school hours; and
(d) The student's parent or guardian has completed and submitted to
the school any written documentation required by the school, including
the treatment plan formulated under (c) of this subsection and other
documents related to liability.
(4) An authorization granted under subsection (3) of this section
must allow the student involved to possess and use his or her
medication:
(a) While in school;
(b) While at a school-sponsored activity, such as a sporting event;
and
(c) In transit to or from school or school-sponsored activities.
(5) An authorization granted under subsection (3) of this section:
(a) Must be effective only for the same school and school year for
which it is granted; and
(b) Must be renewed by the parent or guardian each subsequent
school year in accordance with this subsection.
(6) School districts must require that backup medication, if
provided by a student's parent or guardian, be kept at a student's
school in a location to which the student has immediate access in the
event of an asthma or anaphylaxis emergency.
(7) School districts must require that information described in
subsection (3)(c) and (d) of this section be kept on file at the
student's school in a location easily accessible in the event of an
asthma or anaphylaxis emergency.
(8) Nothing in this section creates a cause of action or in any
other way increases or diminishes the liability of any person under any
other law.
Sec. 3 RCW 41.05.013 and 2003 c 276 s 1 are each amended to read
as follows:
(1) The authority shall coordinate state agency efforts to develop
and implement uniform policies across state purchased health care
programs that will ensure prudent, cost-effective health services
purchasing, maximize efficiencies in administration of state purchased
health care programs, improve the quality of care provided through
state purchased health care programs, and reduce administrative burdens
on health care providers participating in state purchased health care
programs. The policies adopted should be based, to the extent
possible, upon the best available scientific and medical evidence and
shall endeavor to address:
(a) Methods of formal assessment, such as health technology
assessment. Consideration of the best available scientific evidence
does not preclude consideration of experimental or investigational
treatment or services under a clinical investigation approved by an
institutional review board;
(b) Monitoring of health outcomes, adverse events, quality, and
cost-effectiveness of health services;
(c) Development of a common definition of medical necessity; and
(d) Exploration of common strategies for disease management and
demand management programs, including asthma, diabetes, heart disease,
and similar common chronic diseases. Strategies to be explored include
individual asthma management plans. On January 1, 2007, and January 1,
2009, the authority shall issue a status report to the legislature
summarizing any results it attains in exploring and coordinating
strategies for asthma, diabetes, heart disease, and other chronic
diseases.
(2) The administrator may invite health care provider
organizations, carriers, other health care purchasers, and consumers to
participate in efforts undertaken under this section.
(3) For the purposes of this section "best available scientific and
medical evidence" means the best available external clinical evidence
derived from systematic research.
NEW SECTION. Sec. 4 A new section is added to chapter 43.70 RCW
to read as follows:
(1) The department, in collaboration with its public and private
partners, shall design a state asthma plan, based on clinically sound
criteria including nationally recognized guidelines such as those
established by the national asthma education prevention partnership
expert panel report guidelines for the diagnosis and management of
asthma.
(2) The plan shall include recommendations in the following areas:
(a) Evidence-based processes for the prevention and management of
asthma;
(b) Data systems that support asthma prevalence reporting,
including population disparities and practice variation in the
treatment of asthma;
(c) Quality improvement strategies addressing the successful
diagnosis and management of the disease; and
(d) Cost estimates and sources of funding for plan implementation.
(3) The department shall submit the completed state plan to the
governor and the legislature by December 1, 2005. After the initial
state plan is submitted, the department shall provide progress reports
to the governor and the legislature on a biennial basis beginning
December 1, 2007.
(4) The department shall implement the state plan recommendations
made under subsection (2) of this section only to the extent that
federal, state, or private funds, including grants, are available for
that purpose.